{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:23:38Z","timestamp":1792013018975,"version":"4.4.0"},"reference-count":79,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T00:00:00Z","timestamp":1741478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is considered a significant global health issue related to serious metabolic disorders. However, effective pharmacological treatments are still limited. Flavonoids, a wide group of polyphenol substances, exert anti-inflammatory and lipid-lowering effects in preclinical data. Thus, implementing these research findings in clinical practice could significantly help manage NAFLD and its consequences. This narrative review assesses the therapeutic potential of flavonoids in managing NAFLD. The research collected randomized controlled trials (RCTs) and meta-analyses of RCTs from the past five years concerning the impact of flavonoids on NAFLD. A total of 20 studies were selected according to predetermined inclusion criteria, comprising thirteen randomized controlled trials (RCTs) and seven meta-analyses. The research underscores the beneficial effects of flavonoids in the management of NAFLD through the enhancement of lipid metabolism, the reduction in hepatic steatosis, and the provision of anti-inflammatory actions. Clinical trials demonstrate that interventions rich in flavonoids, including quercetin, epigallocatechin gallate, naringenin, and isoflavones, substantially reduce liver fat content and enhance liver enzyme profiles, with certain compounds exhibiting superior efficacy in particular subgroups, such as older adults and females. Nonetheless, whereas these therapies significantly diminish hepatic steatosis, their effect on fibrosis is constrained. To sum up, flavonoids exhibit significant potential as supplementary treatments for NAFLD by enhancing liver function, lipid metabolism, and inflammation. Additional extensive controlled clinical trials are necessary to create uniform treatment methods and ascertain their long-term therapeutic advantages.<\/jats:p>","DOI":"10.3390\/nu17060956","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:02:59Z","timestamp":1741608179000},"page":"956","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical Insights into Non-Alcoholic Fatty Liver Disease and the Therapeutic Potential of Flavonoids: An Update"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6596-7269","authenticated-orcid":false,"given":"Aleksandra","family":"Koz\u0142owska","sequence":"first","affiliation":[{"name":"Department of Social Medicine and Public Health, Medical University of Warsaw, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1024\/0300-9831\/a000805","article-title":"Grape seed extract supplementation in non-alcoholic fatty liver disease","volume":"94","author":"Ghanbari","year":"2024","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: How is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"T\u00fcmen, D., Heumann, P., G\u00fclow, K., Demirci, C.N., Cosma, L.S., M\u00fcller, M., and Kandulski, A. (2022). Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123202"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ncp.10449","article-title":"Evolution of NAFLD and Its Management","volume":"35","author":"Mundi","year":"2020","journal-title":"Nutr. Clin. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e2300480","DOI":"10.1002\/mnfr.202300480","article-title":"Does Flavonoid Supplementation Alleviate Non-Alcoholic Fatty Liver Disease? A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"67","author":"Li","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"111326","DOI":"10.1016\/j.biopha.2021.111326","article-title":"New insight and potential therapy for NAFLD: CYP2E1 and flavonoids","volume":"137","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1005312","DOI":"10.3389\/fphar.2022.1005312","article-title":"Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_13","first-page":"79","article-title":"Flavonoids-food sources and health benefits","volume":"65","year":"2014","journal-title":"Rocz. Panstw. Zakl. Hig."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chen, S., Wang, X., Cheng, Y., Gao, H., and Chen, X. (2023). A Review of Classification, Biosynthesis, Biological Activities and Potential Applications of Flavonoids. Molecules, 28.","DOI":"10.3390\/molecules28134982"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-food-041715-033346","article-title":"Unraveling Anthocyanin Bioavailability for Human Health","volume":"7","author":"Lila","year":"2016","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"125040","DOI":"10.1016\/j.foodchem.2019.125040","article-title":"Co-ingestion of red cabbage with cherry tomato enhances digestive bioaccessibility of anthocyanins but decreases carotenoid bioaccessibility after simulated in vitro gastro-intestinal digestion","volume":"298","author":"Phan","year":"2019","journal-title":"Food Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e0128132","DOI":"10.1371\/journal.pone.0128132","article-title":"Flavonoid intake in European adults (18 to 64 years)","volume":"10","author":"Vogiatzoglou","year":"2015","journal-title":"PLoS ONE"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nutres.2018.10.006","article-title":"Estimation of daily intake of flavonoids and major food sources in middle-aged Australian men and women","volume":"61","author":"Murphy","year":"2019","journal-title":"Nutr. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/09637486.2013.832170","article-title":"Intakes of total and individual flavonoids by US adults","volume":"65","author":"Bai","year":"2014","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/advances\/nmab017","article-title":"Dietary Assessment Methods to Estimate (Poly)phenol Intake in Epidemiological Studies: A Systematic Review","volume":"12","author":"Xu","year":"2021","journal-title":"Adv. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Pereira, V., Figueira, O., and Castilho, P.C. (2024). Flavonoids as Insecticides in Crop Protection-A Review of Current Research and Future Prospects. Plants, 13.","DOI":"10.3390\/plants13060776"},{"key":"ref_22","first-page":"173","article-title":"USDA Database for the Flavonoid Content of Selected Foods","volume":"2018","author":"Haytowitz","year":"2018","journal-title":"U.S. Dep. Agric."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"M\u00e9rillon, J.-M., and Ramawat, K.G. (2019). Flavonoids\u2013Food Sources, Health Benefits, and Mechanisms Involved. Bioactive Molecules in Food, Springer International Publishing.","DOI":"10.1007\/978-3-319-78030-6"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949746","DOI":"10.3389\/fimmu.2022.949746","article-title":"Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12272-023-01443-4","article-title":"Phytochemistry and pharmacology of natural prenylated flavonoids","volume":"46","author":"Lv","year":"2023","journal-title":"Arch. Pharm. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1389450116666150804110049","article-title":"Is Intake of Flavonoid-Based Food Supplements During Pregnancy Safe for the Developing Child? A Literature Review","volume":"18","author":"Barenys","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Xie, Y., Zhang, D., Zhang, J., and Yuan, J. (2019). Metabolism, Transport and Drug-Drug Interactions of Silymarin. Molecules, 24.","DOI":"10.3390\/molecules24203693"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.freeradbiomed.2004.04.034","article-title":"Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties","volume":"37","author":"Galati","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kond\u017ea, M., Brizi\u0107, I., and Joki\u0107, S. (2024). Flavonoids as CYP3A4 Inhibitors In Vitro. Biomedicines, 12.","DOI":"10.20944\/preprints202401.0803.v1"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lesjak, M., and KS Srai, S. (2019). Role of Dietary Flavonoids in Iron Homeostasis. Pharmaceuticals, 12.","DOI":"10.3390\/ph12030119"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jsfa.13923","article-title":"Isolation and purification of flavonoids from quinoa whole grain and its inhibitory effect on lipid accumulation in nonalcoholic fatty liver disease by inhibiting the expression of CD36 and FASN","volume":"105","author":"La","year":"2025","journal-title":"J. Sci. Food Agric."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1007\/s12013-024-01413-7","article-title":"Active Targets and Potential Mechanisms of Erhuang Quzhi Formula in Treating NAFLD: Network Analysis and Experimental Assessment","volume":"82","author":"Pan","year":"2024","journal-title":"Cell Biochem. Biophys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e2400554","DOI":"10.1002\/mnfr.202400554","article-title":"Grape-Seed Proanthocyanidin Extract (GSPE) Modulates Diurnal Rhythms of Hepatic Metabolic Genes and Metabolites, and Reduces Lipid Deposition in Cafeteria-Fed Rats in a Time-of-Day-Dependent Manner","volume":"68","author":"Calvo","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1111\/1750-3841.17025","article-title":"Vine tea total flavonoids activate the AMPK\/mTOR pathway to amelioration hepatic steatosis in mice fed a high-fat diet","volume":"89","author":"Wang","year":"2024","journal-title":"J. Food Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"113035","DOI":"10.1016\/j.intimp.2024.113035","article-title":"Novel insights into the role of quercetin and kaempferol from Carthamus tinctorius L. in the management of nonalcoholic fatty liver disease via NR1H4-mediated pathways","volume":"143","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","article-title":"Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway","volume":"22","author":"Yang","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1336232","DOI":"10.3389\/fphar.2024.1336232","article-title":"Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"176800","DOI":"10.1016\/j.ejphar.2024.176800","article-title":"Apigenin-6-C-glucoside ameliorates MASLD in rodent models via selective agonism of adiponectin receptor 2","volume":"978","author":"Khatoon","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/13813455.2022.2138445","article-title":"Silymarin inhibits the lipogenic pathway and reduces worsening of non-alcoholic fatty liver disease (NAFLD) in mice","volume":"130","author":"Carvalho","year":"2024","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"La, X., Zhang, Z., Dong, C., Li, H., He, X., Kang, Y., Wu, C., and Li, Z. (2024). Isorhamnetin in Quinoa Whole-Grain Flavonoids Intervenes in Non-Alcoholic Fatty Liver Disease by Modulating Bile Acid Metabolism through Regulation of FXR Expression. Foods, 13.","DOI":"10.3390\/foods13193076"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2442351","DOI":"10.1080\/10495398.2024.2442351","article-title":"Quercetin alleviates metabolic-associated fatty liver disease by tuning hepatic lipid metabolism, oxidative stress and inflammation","volume":"36","author":"Jiang","year":"2025","journal-title":"Anim. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Yang, H., Li, D., and Gao, G. (2024). Kaempferol Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis (NASH) by Suppressing Neutrophil-Mediated NLRP3-ASC\/TMS1-Caspase 3 Signaling. Molecules, 29.","DOI":"10.3390\/molecules29112630"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/ptr.8207","article-title":"7-Hydroxyflavone improves nonalcoholic fatty liver disease by acting on STK24","volume":"38","author":"Qi","year":"2024","journal-title":"Phytother. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"159497","DOI":"10.1016\/j.bbalip.2024.159497","article-title":"Total flavonoids of Broussonetia papyrifera alleviate non-alcohol fatty liver disease via regulating Nrf2\/AMPK\/mTOR signaling pathways","volume":"1869","author":"Wang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Guo, X., Yin, X., Liu, Z., and Wang, J. (2022). Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415489"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ueg2.12525","article-title":"Therapeutic management of metabolic dysfunction associated steatotic liver disease","volume":"12","author":"Zeng","year":"2024","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e30387","DOI":"10.1016\/j.heliyon.2024.e30387","article-title":"From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences","volume":"10","author":"Samy","year":"2024","journal-title":"Heliyon"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: Etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"109330","DOI":"10.1016\/j.steroids.2023.109330","article-title":"Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style","volume":"203","author":"Zuo","year":"2024","journal-title":"Steroids"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fendo.2020.00494","article-title":"Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years","volume":"11","author":"Ferro","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ajcnut.2024.07.013","article-title":"Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled crossover clinical trial","volume":"120","author":"Li","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Notarnicola, M., Tutino, V., De Nunzio, V., Cisternino, A.M., Cofano, M., Donghia, R., Giannuzzi, V., Zappimbulso, M., Milella, R.A., and Giannelli, G. (2024). Daily Orange Consumption Reduces Hepatic Steatosis Prevalence in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Exploratory Outcomes of a Randomized Clinical Trial. Nutrients, 16.","DOI":"10.3390\/nu16183191"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"994","DOI":"10.14309\/ajg.0000000000001072","article-title":"Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD","volume":"116","author":"Pirola","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.clnu.2024.06.018","article-title":"Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4","volume":"43","author":"Yang","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1186\/s12889-024-18812-3","article-title":"The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: A randomized placebo controlled clinical trial","volume":"24","author":"Hatami","year":"2024","journal-title":"BMC Public. Health"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","article-title":"Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease","volume":"6","author":"Baumeier","year":"2017","journal-title":"Mol. Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1038\/s41598-024-55747-6","article-title":"The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A","volume":"14","author":"Hatami","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pop.2023.03.007","article-title":"Approach to Elevated Liver Enzymes","volume":"50","author":"Rosenberg","year":"2023","journal-title":"Prim. Care"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gtc.2019.09.002","article-title":"How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis","volume":"49","author":"Henry","year":"2020","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"111092","DOI":"10.1016\/j.nut.2020.111092","article-title":"Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"83","author":"Kalopitas","year":"2021","journal-title":"Nutrition"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.aohep.2023.101174","article-title":"Administration of silymarin in NAFLD\/NASH: A systematic review and meta-analysis","volume":"29","author":"Li","year":"2024","journal-title":"Ann. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1002\/ptr.8182","article-title":"Effects of different natural products in patients with non-alcoholic fatty liver disease-A network meta-analysis of randomized controlled trials","volume":"38","author":"Liu","year":"2024","journal-title":"Phytother. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/ptr.6637","article-title":"Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials","volume":"34","author":"Mahmoodi","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e37052","DOI":"10.1097\/MD.0000000000037052","article-title":"Efficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"114991","DOI":"10.1016\/j.biopha.2023.114991","article-title":"The great potential of flavonoids as candidate drugs for NAFLD","volume":"164","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pharma.2024.02.005","article-title":"Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease","volume":"82","author":"Mandal","year":"2024","journal-title":"Ann. Pharm. Fr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: A clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6696857","DOI":"10.1155\/2021\/6696857","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter","volume":"2021","author":"Chiriac","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000002323","article-title":"Effects of naringenin supplementation on cardiovascular risk factors in overweight\/obese patients with nonalcoholic fatty liver disease: A pilot double-blind, placebo-controlled, randomized clinical trial","volume":"34","author":"Naeini","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e14852","DOI":"10.1111\/ijcp.14852","article-title":"Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight\/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial","volume":"75","author":"Namkhah","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41430-020-0679-3","article-title":"The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: An open-labeled randomized controlled trial","volume":"75","author":"Yari","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/CLEP.S403314","article-title":"Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis","volume":"15","author":"Sun","year":"2023","journal-title":"Clin. Epidemiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fendo.2020.00179","article-title":"Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: Mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Ferro, Y., Maurotti, S., Mazza, E., Pujia, R., Sciacqua, A., Musolino, V., Mollace, V., Pujia, A., and Montalcini, T. (2022). Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease. Medicina, 58.","DOI":"10.3390\/medicina58121728"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"101843","DOI":"10.1016\/j.clinre.2021.101843","article-title":"Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study","volume":"46","author":"Zhu","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/6\/956\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:44Z","timestamp":1760028584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/6\/956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,9]]},"references-count":79,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["nu17060956"],"URL":"https:\/\/doi.org\/10.3390\/nu17060956","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,9]]}}}